Overview


According to FutureWise analysis the market for respiratory pathogen testing kits in 2023 is US$ 2.46 billion, and is expected to reach US$ 3.84 billion by 2031 at a CAGR of 5.70%.

A respiratory pathogen testing kit is used to identify respiratory infections by analysing blood, fluids, or tissue from an affected part of the body. Some of the most prevalent infections' genetic material (RNA/DNA) is detected by respiratory pathogen testing kits. It can identify more than one bacterium causing illness and find bacteria that standard tests, such as cultures, may miss. A few testing kits can detect microorganism subgroups or strains. Respiratory tract blockage is caused by uncontrolled breathing of different gases such as sulphur dioxide and carbon monoxide. Respiratory pathogen testing kits may identify numerous bacterial fungal viral illnesses in the respiratory system. There are several types of respiratory pathogen testing for children, including lateral flow tests, also known as immunochromatographic assays, direct fluorescent antibody (DFA) tests, agglutination assays, reverse transcription-polymerase chain reaction (RT-PCR) tests, solid-phase assays, and flow-through assays.

The prevalence of respiratory sickness is rapidly increasing. As a result of changing environmental landscapes caused by urbanisation, air quality has deteriorated, providing a breeding ground for disease-causing organisms. Pneumonia, the common cold, influenza, tuberculosis, bronchitis, and COVID-19 are driving technological improvements in the detection and treatment of respiratory disorders. Because of the COVID-19 pandemic, healthcare and pharmaceutical industries are accelerating research and development on a number of enhanced respiratory pathogen diagnostic kits. As the number of infections climbs daily, hospitals and clinics are struggling to keep up with the rising patient population. This is due to significant shortages of medical equipment, beds, protective clothing, and testing kits.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Respiratory Pathogen Testing Kits Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Respiratory Pathogen Testing Kits Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Hoffmann-La Roche Inc.
  • Seegene Inc
  • Fast Track Diagnostics Ltd
  • PathoFinder BV.
  • Daan Gene Co Ltd
  • Veredus Laboratories Pte Ltd
  • True Health Diagnostics LLC
  • Genetic Signatures Ltd
  • Beijing Baicare BioTechnique Co Ltd
  • Cue Health Inc
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Sysmex Corp
  • Beckman Coulter Inc
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc
  • Qiagen NV
  • bioMerieux SA
  • Horiba Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • RT PCR kits
  • DFA Kits
  • ELISA Kits
  • Others

By Indications

  • Enterovirus Infection
  • Human Coronavirus Infection
  • Influenza Virus Infection
  • Respiratory Syncytial Virus Infection
  • Rhinovirus Infection
  • Pneumonia
  • Others

By Technology

  • NAAT (Nucliec Acid Amplification)
  • Immunoassay
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Speciality Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Respiratory Pathogen Testing Kits Market By Product Type, By Indications, By Technology, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Respiratory Pathogen Testing Kits Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Respiratory Pathogen Testing Kits Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Respiratory Pathogen Testing Kits Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Respiratory Pathogen Testing Kits Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. RT PCR kits
        2. DFA Kits
        3. ELISA Kits
        4. Others

  • 8.   Respiratory Pathogen Testing Kits Market, By Indications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Enterovirus Infection
        2. Human Coronavirus Infection
        3. Influenza Virus Infection
        4. Respiratory Syncytial Virus Infection
        5. Rhinovirus Infection
        6. Pneumonia
        7. Others

  • 9.   Respiratory Pathogen Testing Kits Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. NAAT (Nucliec Acid Amplification)
        2. Immunoassay
        3. Others

  • 10.   Respiratory Pathogen Testing Kits Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Centers
        3. Speciality Clinics

  • 11.   North America Respiratory Pathogen Testing Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Respiratory Pathogen Testing Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Respiratory Pathogen Testing Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Respiratory Pathogen Testing Kits Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hoffmann-La Roche Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Seegene Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Fast Track Diagnostics Ltd
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. PathoFinder BV
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Daan Gene Co Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Veredus Laboratories Pte Ltd
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. True Health Diagnostics LLC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Genetic Signatures Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Beijing Baicare BioTechnique Co Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cue Health Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Siemens Healthineers AG
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Abbott Laboratories
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Sysmex Corp
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Beckman Coulter Inc
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Danaher Corp
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Bio-Rad Laboratories Inc
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Thermo Fisher Scientific Inc
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Qiagen NV
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. bioMerieux SA
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Horiba Ltd
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients